Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Jun 2

PMID 34071546

Citations 21

Authors

Patrycja Szybowska

Michal Kostas

Jorgen Wesche

Ellen Margrethe Haugsten

Antoni Wiedlocha

Affiliations

Soon will be listed here.

Abstract

FGFR (fibroblast growth factor receptor) signaling controls fundamental processes in embryonic, fetal and adult human life. The magnitude, duration, and location of FGFR signaling must be strictly controlled in order to induce the correct biological response. Uncontrolled receptor signaling has been shown to lead to a variety of diseases, such as skeletal disorders and cancer. Here we review the numerous cellular mechanisms that regulate and turn off FGFR signaling, once the receptor is activated. These mechanisms include endocytosis and endocytic sorting, phosphatase activity, negative regulatory proteins and negative feedback phosphorylation events. The mechanisms act together simultaneously or sequentially, controlling the same or different steps in FGFR signaling. Although more work is needed to fully understand the regulation of FGFR signaling, it is clear that the cells in our body have evolved an extensive repertoire of mechanisms that together keep FGFR signaling tightly controlled and prevent excess FGFR signaling.

Citing Articles

Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells.

Hausott B, Pircher L, Kind M, Park J, Claus P, Obexer P Cells. 2024; 13(23).

PMID: 39682716 PMC: 11639775. DOI: 10.3390/cells13231967.

The roles of FGFR3 and c-MYC in urothelial bladder cancer.

Bogale D Discov Oncol. 2024; 15(1):295.

PMID: 39031286 PMC: 11264706. DOI: 10.1007/s12672-024-01173-z.

Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR).

Cheng M, Abdullah F, Buechler M F1000Res. 2024; 13:120.

PMID: 38988879 PMC: 11234085. DOI: 10.12688/f1000research.143514.2.

HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma.

Li T, Liu L, Li L, Yao X, Hu X, Cheng J Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794215 PMC: 11125149. DOI: 10.3390/ph17050645.

The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis.

Zukowska D, Chorazewska A, Ciura K, Gedaj A, Kalka M, Pozniak M Cell Commun Signal. 2024; 22(1):270.

PMID: 38750548 PMC: 11094976. DOI: 10.1186/s12964-024-01661-3.

References

Goh L, Sorkin A . Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol. 2013; 5(5):a017459. PMC: 3632065. DOI: 10.1101/cshperspect.a017459. View

Stowe I, Mercado E, Stowe T, Bell E, Oses-Prieto J, Hernandez H . A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1. Genes Dev. 2012; 26(13):1421-6. PMC: 3403010. DOI: 10.1101/gad.190876.112. View

Kovalenko D, Yang X, Chen P, Nadeau R, Zubanova O, Pigeon K . A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling. Cell Signal. 2006; 18(11):1958-66. DOI: 10.1016/j.cellsig.2006.03.001. View

Coleman S, Bruce C, Chioni A, Kocher H, Grose R . The ins and outs of fibroblast growth factor receptor signalling. Clin Sci (Lond). 2014; 127(4):217-31. DOI: 10.1042/CS20140100. View

Kilkenny D, Rocheleau J . The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions. Vitam Horm. 2016; 101:17-58. DOI: 10.1016/bs.vh.2016.02.008. View

Hausott B, Rietzler A, Vallant N, Auer M, Haller I, Perkhofer S . Inhibition of fibroblast growth factor receptor 1 endocytosis promotes axonal branching of adult sensory neurons. Neuroscience. 2011; 188:13-22. DOI: 10.1016/j.neuroscience.2011.04.064. View

Hausott B, Forste A, Zach F, Mangger S, Haugsten E, Klimaschewski L . Endocytosis and Transport of Growth Factor Receptors in Peripheral Axon Regeneration: Novel Lessons from Neurons Expressing Lysine-Deficient FGF Receptor Type 1 in vitro. Anat Rec (Hoboken). 2019; 302(8):1268-1275. PMC: 6767123. DOI: 10.1002/ar.24120. View

Ekerot M, Stavridis M, Delavaine L, Mitchell M, Staples C, Owens D . Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter. Biochem J. 2008; 412(2):287-98. PMC: 2474557. DOI: 10.1042/BJ20071512. View

Itoh N, Ornitz D . Evolution of the Fgf and Fgfr gene families. Trends Genet. 2004; 20(11):563-9. DOI: 10.1016/j.tig.2004.08.007. View

10.

Hsu T, Adereth Y, Kose N, Dammai V . Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility. J Biol Chem. 2006; 281(17):12069-80. PMC: 2367321. DOI: 10.1074/jbc.M511621200. View

11.

Mardakheh F, Yekezare M, Machesky L, Heath J . Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling. J Cell Biol. 2009; 187(2):265-77. PMC: 2768835. DOI: 10.1083/jcb.200905118. View

12.

Wesche J, Haglund K, Haugsten E . Fibroblast growth factors and their receptors in cancer. Biochem J. 2011; 437(2):199-213. DOI: 10.1042/BJ20101603. View

13.

Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di Fiore P . Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell. 2008; 15(2):209-19. DOI: 10.1016/j.devcel.2008.06.012. View

14.

Vietri M, Radulovic M, Stenmark H . The many functions of ESCRTs. Nat Rev Mol Cell Biol. 2019; 21(1):25-42. DOI: 10.1038/s41580-019-0177-4. View

15.

Sorokin A, Mohammadi M, Huang J, Schlessinger J . Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J Biol Chem. 1994; 269(25):17056-61. View

16.

Itoh N, Ornitz D . Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem. 2010; 149(2):121-30. PMC: 3106964. DOI: 10.1093/jb/mvq121. View

17.

Belleudi F, Leone L, Maggio M, Torrisi M . Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Exp Cell Res. 2009; 315(13):2181-91. DOI: 10.1016/j.yexcr.2009.03.022. View

18.

Darby S, Murphy T, Thomas H, Robson C, Leung H, Mathers M . Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease. Br J Cancer. 2009; 101(11):1891-9. PMC: 2788253. DOI: 10.1038/sj.bjc.6605379. View

19.

Guo C, Degnin C, Laederich M, Lunstrum G, Holden P, Bihlmaier J . Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia. Cell Signal. 2008; 20(8):1471-7. PMC: 2675614. DOI: 10.1016/j.cellsig.2008.04.001. View

20.

Porebska N, Latko M, Kucinska M, Zakrzewska M, Otlewski J, Opalinski L . Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment. J Clin Med. 2018; 8(1). PMC: 6352210. DOI: 10.3390/jcm8010007. View